Exact FDA event identifier

Event 95520

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: October 08, 2024
Product types: Drug
Classifications: Class II
Statuses: Ongoing
Recalling firm wording: C & A Naturistics

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas, 400 mg,

D-0024-2025

Recall number: D-0024-2025
Initiated: October 08, 2024
Classification: Class II
Status: Ongoing
Recalling firm: C & A Naturistics
Quantity: Unknown

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0

Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen.

Code information

All Lots

Distribution pattern

Nationwide within the United States